Pyridostigmine Bromide
- Product NDC
- 68682-302
- 11-digit product format
- 686820302
- Labeler code
- 68682
- Product ID
- 68682-302_ae224c35-5c76-4a51-a7b3-ac20f5e92bca
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pyridostigmine Bromide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Oceanside Pharmaceuticals
- Application
- NDA009829
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2007-10-30
- Substance
- PYRIDOSTIGMINE BROMIDE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pyridostigmine Bromide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PYRIDOSTIGMINE BROMIDE | 60 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KVI301NA53 |
| Rxcui | 903857 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68682-302-10 | Pyridostigmine Bromide | 100 in 1 BOTTLE | TABLET | 100 | | 7 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68682-302 | PYRIDOSTIGMINE BROMIDE TABLET [OCEANSIDE PHARMACEUTICALS] | 7 | Current NDC, Legacy NDC, 1 package rows | 20200623_7e51c874-78f9-4f95-997a-4d09272a8890.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68682-302-10 | 68682030210 | 100 TABLET in 1 BOTTLE (68682-302-10) | 100 tablet | 2007-10-30 | 0000-00-00 | No | No | Current |